ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Gates biomanufacturing facility announces agreement with Nkarta
November 08, 2021The Gates Biomanufacturing Facility (GBF) has announced a continued strategic agreement with Nkarta to manufacture clinical supply of therapeutic natural killer cells. -
Nkarta raises $114m to bring cancer therapies into clinic
September 10, 2019US-based biopharmaceutical firm Nkarta Therapeutics has raised $114m in series B funding round to advance its natural killer (NK) cell-based cancer drug candidates into clinical trials.
Pharma Sources Insight January 2025
